Hi, what are you looking for?
Jewish Business News
Search results for " Yitzhak Peterburg"
Leadership & A-List
– Teva Pharmaceutical Industries Ltd. ((NYSE: TEVA; TASE: TEVA) today announced that the Board of Directors has elected Professor Yitzhak Peterburg as Chairman, effective January 1,...
Business
Teva appointed Dr. Yitzhak Peterburg as Interim, succeeding Erez Vigodman. Dr. Sol J. Barer named Chairman of the Board
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Life science
Teva shares rose 6% at the end of trading in New York after Berkshire Hathaway, the investment company controlled by Warren Buffett, revealed...
Life science
Kare Schultz brings Global Pharmaceutical experience, Including at Lundbeck and Novo Nordisk Proven Track Record of Implementing Turnaround Strategies
Business
The Israeli Pharma share is losing about 33% in two trading days and erasing a huge sum of $10 billion from its market value
Business
Teva will close 15 plants by the end of 2018 and exit from 45 countries by the end of 2017 ■ The company expects...
Business
Judge rules against Israeli pharma firm in its suit over alleged fraud by Mexican Espinosa brothers; Teva posts $5.7 billion 2Q revenue - less...
Business
IBM and Israel’s Teva Pharmaceutical Ltd have announced plans for the two companies to increase their existing global e-Health alliance. The announcement was made...
Business
The deal, the largest ever acquisition by an Israeli company, is in cash and shares.